Compound details
Citronellyl cinnamate
| Compound ID | CDAMM01001 |
|---|---|
| Common name | Citronellyl cinnamate | IUPAC name | 3,7-dimethyloct-6-enyl 3-phenylprop-2-enoate |
| Molecular formula | C19H26O2 |
| Retention time | 16.94 |
|---|---|
| Adduct | [2M+H]+ |
| Actual mz | 573.386 | Theoretical mz | 573.393 |
| Error | 12.17 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.0775 |
| Inchi key | KMXKQELDKDGFRN-OUKQBFOZNA-N |
|---|---|
| Smiles | O=C(OCCC(C)CCC=C(C)C)C=CC=1C=CC=CC1 |
| Superclass | Lipids and lipid-like molecules |
| Class | Fatty Acyls |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q8TDS4 | HCAR2 | Hydroxycarboxylic acid receptor 2 | T88185 | SEA |
| P02766 | TTR | Transthyretin | T86462 | SEA |
| Q96RI1 | NR1H4 | Bile acid receptor FXR | T51426 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SEA |
| P39086 | GRIK1 | Glutamate receptor ionotropic kainate 1 | T73495 | SEA |
| Q13002 | GRIK2 | Glutamate receptor ionotropic kainate 2 | T58178 | SEA |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SEA |
| P42330 | AKR1C3 | Aldo-keto-reductase family 1 member C3 | T60857 | SEA |
| P18031 | PTPN1 | Protein-tyrosine phosphatase 1B | T16347 | SwissTargetPrediction |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SwissTargetPrediction |
| P09917 | ALOX5 | Arachidonate 5-lipoxygenase | T00140 | SEA |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P25116 | F2R | Proteinase-activated receptor 1 | T36483 | SEA |
| P19438 | TNFRSF1A | Tumor necrosis factor receptor R1 | T86552 | SEA |
| P21462 | FPR1 | Formyl peptide receptor 1 | T87831 | SEA |
| O75884 | RBBP9 | Putative hydrolase RBBP9 | T12084 | SEA |
| P21757 | MSR1 | Macrophage scavenger receptor types I and II | T50007 | SEA |
| Q9BY41 | HDAC8 | Histone deacetylase 8 | T28887 | SEA |
| P04632 | CAPNS1 | HUMAN calpain-1 or calpain small subunit 1 heterodimer | T00099 | SEA |
| P01100 | FOS | Proto-oncogene c-Fos | T28025 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T88185 | DI0203 | Inborn lipid metabolism error | [ICD-11: 5C52] | Q8TDS4 | HCAR2 |
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T51426 | DI0043 | Autoimmune liver disease | [ICD-11: DB96] | Q96RI1 | NR1H4 |
| T51426 | DI0077 | Cholelithiasis | [ICD-11: DC11] | Q96RI1 | NR1H4 |
| T51426 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q96RI1 | NR1H4 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T73495 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P39086 | GRIK1 |
| T73495 | DI0396 | Substance abuse | [ICD-11: 6C40] | P39086 | GRIK1 |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T60857 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P42330 | AKR1C3 |
| T16347 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P18031 | PTPN1 |
| T16347 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P18031 | PTPN1 |
| T16347 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18031 | PTPN1 |
| T16347 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P18031 | PTPN1 |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T00140 | DI0037 | Asthma | [ICD-11: CA23] | P09917 | ALOX5 |
| T00140 | DI0147 | Filariasis | [ICD-11: 1F66] | P09917 | ALOX5 |
| T00140 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09917 | ALOX5 |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T36483 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P25116 | F2R |
| T86552 | DI0060 | Brain cancer | [ICD-11: 2A00] | P19438 | TNFRSF1A |
| T86552 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P19438 | TNFRSF1A |
| T87831 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P21462 | FPR1 |
| T28887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9BY41 | HDAC8 |
| T00099 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P04632 | CAPNS1 |